Table 4.
Procedure | Total (n = 12,888) | Multinodular Goitre (n = 9069) | Graves’ Disease (n = 925) | Other Entities (n = 2894) |
---|---|---|---|---|
Neuromonitoring RLN | ||||
no | 202 (1.6%) | 133 (1.5%) | 13 (1.4%) | 56 (1.9%) |
yes | 12,686 (98.4%) | 8936 (98.5%) | 912 (98.6%) | 2837 (98.1%) |
intermittent IONM | 10,488 (82.6%) | 7430 (83.1%) | 705 (77.3%) | 2352 (82.9%) |
continuous IONM | 2198 (17.4%) | 1506 (16.9%) | 207 (22.7%) | 485 (17.1%) |
Neuromonitoring SLN | ||||
yes | 997 (7.7%) | 623 (6.9%) | 67 (7.2%) | 307 (10.6%) |
no | 11,891 (92.3%) | 8446 (93.1%) | 858 (92.8%) | 2587 (89.4%) |
Identification PG | ||||
no | 324 (2.5%) | 226 (2.5%) | 6 (0.6%) | 92 (3.2%) |
yes | 12,564 (97.5) | 8843 (97.5%) | 919 (99.4%) | 2802 (97.8%) |
1 PG | 1043 (8.1%) | 679 (7.5%) | 12 (1.3%) | 352 (12.2%) |
2 or more PG | 11,521 (89.3%) | 8164 (90%) | 907 (98.1%) | 2450 (84.7%) |
Autotransplantation PG | ||||
yes | 1875 (15.3%) | 1326 (14.6%) | 206 (22.3%) * | 343 (11.9%) |
no | 11,013 (84.7%) | 7743 (85.4%) | 719 (77.7%) | 2551 (88.1%) |
RLN—recurrent laryngeal nerve; SLN-external branch superior laryngeal nerve; PG—parathyroid gland; IONM—intraoperative neuromonitoring; * p < 0.05 Graves’ disease vs. multinodular goitre and other entities combined.